๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-09
Trial ID
NCT02577458
Treatments Being Tested
The objective of this study is to evaluate the safety and preliminary biolo...
Status
Completed
Location
Retina Vitreous Associates Medical Group
Start Date
2012-10
Trial ID
NCT01674569
Treatments Being Tested
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Status
Suspended
Location
Peking Union Medical College Hospital
Start Date
2019-12-18
Trial ID
NCT04222842
Treatments Being Tested
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2019-02-26
Trial ID
NCT03792958
Treatments Being Tested
This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Status
Completed
Location
Beijing University First Hospital
Start Date
2013-05
Trial ID
NCT01863485
Treatments Being Tested
The purpose of the study is to determine whether adding vorolanib to atezol...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2020-10-07
Trial ID
NCT04373369
Treatments Being Tested
This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Status
Suspended
Location
Peking University People's Hospital
Start Date
2015-03
Trial ID
NCT02452385
Treatments Being Tested
This study is to evaluate the combination of an investigational drug X-82 w...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2013-05-03
Trial ID
NCT01784861
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Sarah Cannon Research Institute
Start Date
2011-02
Trial ID
NCT01296581
Treatments Being Tested
This is a Phase II Study to Evaluate the Safety, Tolerability, Pharmacokine...
Status
Unknown
Location
Renmin Hospital of Wuhan University, Hubei General Hospital
Start Date
2018-11-22
Trial ID
NCT03710863
Treatments Being Tested